Chronic granulocytic leukaemia in accelerated stage treated with low dose cytosine arabinoside. 1985

A Waage, and J Hammerstrøm, and J Lamvik

UI MeSH Term Description Entries
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Waage, and J Hammerstrøm, and J Lamvik
November 1985, British journal of haematology,
A Waage, and J Hammerstrøm, and J Lamvik
March 1987, European journal of haematology,
A Waage, and J Hammerstrøm, and J Lamvik
April 1986, British journal of haematology,
A Waage, and J Hammerstrøm, and J Lamvik
June 1978, Annals of the rheumatic diseases,
A Waage, and J Hammerstrøm, and J Lamvik
September 1995, European journal of haematology,
A Waage, and J Hammerstrøm, and J Lamvik
July 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
A Waage, and J Hammerstrøm, and J Lamvik
March 1996, [Rinsho ketsueki] The Japanese journal of clinical hematology,
A Waage, and J Hammerstrøm, and J Lamvik
March 1985, Scandinavian journal of haematology,
A Waage, and J Hammerstrøm, and J Lamvik
January 1971, Clinical pharmacology and therapeutics,
A Waage, and J Hammerstrøm, and J Lamvik
July 1982, British journal of haematology,
Copied contents to your clipboard!